Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

VirtualScopics Inc

+ Add to Watchlist

VSCP:US

2.7990 USD 0.0090 0.32%

As of 20:10:00 ET on 04/23/2015.

Snapshot for VirtualScopics Inc (VSCP)

Open: 2.5610 Day's Range: 2.5610 - 2.7990 Volume: 1,064
Previous Close: 2.7900 52wk Range: 2.5500 - 5.8500 1-Yr Rtn: -28.78%

Stock Chart for VSCP

No chart data available.
  • VSCP:US 2.7990
  • 1D
  • 1M
  • 1Y
2.7900
Interactive VSCP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VSCP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -1.2000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.38
Shares Outstanding (M) 2.99
30 Day Average Volume 2,710
Price/Book (mrq) 1.7293
Price/Sale (ttm) 0.8016
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VSCP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VSCP

VirtualScopics, Inc. offers image analysis services to the pharmaceuticals industry. The Company analyzes biological structures from computed tomography, magnetic resonance imaging, positron emission tomography, and ultrasound to detect disease progression or therapeutic benefit.

Eric T ConversePresident/CEOJames Groff "Jim"Chief Financial Officer
More Company Profile & Key Executives for VSCP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil